Aquanaz PSE is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Capital Pharmaceutical, Llc. The primary component is Dextromethorphan Hydrobromide; Guaifenesin; Pseudoephedrine Hydrochloride.
Product ID | 29978-588_a50074cd-d831-ca26-e053-2a95a90a6bc9 |
NDC | 29978-588 |
Product Type | Human Otc Drug |
Proprietary Name | Aquanaz PSE |
Generic Name | Dextromethorphan Hbr, Guafenesin, Pseudoephedrine Hcl |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2020-05-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Capital Pharmaceutical, LLC |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 20 mg/1; mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2020-05-01 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AQUANAZ 86701831 4893135 Live/Registered |
Young, Scott 2015-07-22 |